• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Application

  • Print
  • Share
  • E-mail
-

Federal Register
Friday July 11, 2003

Planning to Submit Comments?

Documents and comments received by the Division of Dockets Management may be posted on the Internet. Please do not include personal identifying information, i.e. date of birth, social security number, medical information, etc., in your correspondence.
Submit Electronic Comments

Documents are on display for public inspection at the Division of Dockets Management, 5630 Fishers Lane (Room 1061), HFA-305, Rockville, MD, 20852; 301-827-6860; TTY/TDD Users 1-800-735-2258.


FDA Federal Register Documents

PROPOSED RULES

Docket No. 03N-0076, CFSAN 20038.  Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer Research to Consider Nutrient Content and Health Claims and Possible Footnote or Disclosure Statements.  Pages  41507-41510 [FR Doc. 03-17526 ]  [TXT] [PDF] [PRE-PUB] Comments October 9, 2003

NOTICES-DRAFT GUIDANCES

Docket No. 03N-0069, CFSAN 200352.  Release of Task Force Report; Guidance for Industry and FDA: Interim Evidence-Based Ranking System for Scientific Data;Interim Procedures for Health Claims on the Labeling of Conventional Human Food and Human Dietary Supplements; Availability.  Pages  41387--41390 [FR Doc. 03-17702]  [TXT] [PDF] [PRE-PUB]

The Guidance Interim Evidence-based Ranking System for Scientific Data. Word
The Guidance Interim Procedures for Qualified Health Claims in the Labeling of Conventional Human Food and Human Dietary Supplements Word
The Guidance Interim Evidence-based Ranking System for Scientific Data. pdf version
The Guidance Interim Procedures for Qualified Health Claims in the Labeling of Conventional Human Food and Human Dietary Supplements pdf version

NOTICES

Docket No. 03N-0017, OC 2003181.  Agency Information Collection Activities; Submission for OMB Review; Comment Request; Impact of Risk Management Programs on the Practice of Pharmacy.  Pages  41384--41385 [FR Doc. 03-17574]  [TXT] [PDF] [PRE-PUB]

ANADA 200-219, CVM 200351.  Notice of Approval of New Animal Drug Application; Ivermectin Pour-On. NOTE: A final rule was not published because ยง 524.1193 (21 CFR 524.1193) did not require amendment.  Pages  41385--41386 [FR Doc. 03-17638 ]  [TXT] [PDF] [PRE-PUB]

Freedom of Information Summary

Docket No. 03N-0233 , CDER 20032.  Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients.  Pages  41386--41387 [FR Doc. 03-17637 ]  [TXT] [PDF] [PRE-PUB] Comments October 9, 2003

FINAL RULES

Docket No. 94P-0036, CFSAN 200080.  Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and Health Claims.  Pages  41433--41506 [FR Doc. 03-17525 ]  [TXT] [PDF] [PRE-PUB] Effective January 1, 2006


Table of Contents for Entire Federal Register
Friday, July 11, 2003 (TXT)  (PDF)

-
-